CN103608053B - 用于组装自动注射装置及其子组件的系统、装置和方法 - Google Patents
用于组装自动注射装置及其子组件的系统、装置和方法 Download PDFInfo
- Publication number
- CN103608053B CN103608053B CN201280023943.5A CN201280023943A CN103608053B CN 103608053 B CN103608053 B CN 103608053B CN 201280023943 A CN201280023943 A CN 201280023943A CN 103608053 B CN103608053 B CN 103608053B
- Authority
- CN
- China
- Prior art keywords
- component
- syringe
- exemplary embodiment
- exemplary
- shell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 340
- 238000002347 injection Methods 0.000 title claims abstract description 262
- 239000007924 injection Substances 0.000 title claims abstract description 262
- 238000003780 insertion Methods 0.000 claims description 380
- 230000037431 insertion Effects 0.000 claims description 380
- 230000007246 mechanism Effects 0.000 claims description 200
- 238000000418 atomic force spectrum Methods 0.000 claims description 115
- 238000012360 testing method Methods 0.000 claims description 64
- 238000001514 detection method Methods 0.000 claims description 24
- 239000003814 drug Substances 0.000 claims description 21
- 230000004044 response Effects 0.000 claims description 21
- 229940124597 therapeutic agent Drugs 0.000 claims description 8
- 230000013011 mating Effects 0.000 claims description 3
- 230000008034 disappearance Effects 0.000 claims 2
- 230000008569 process Effects 0.000 abstract description 226
- 230000033001 locomotion Effects 0.000 description 225
- 238000004364 calculation method Methods 0.000 description 149
- 238000010586 diagram Methods 0.000 description 77
- 239000010271 massa medicata fermentata Substances 0.000 description 69
- 230000008859 change Effects 0.000 description 43
- 239000000463 material Substances 0.000 description 31
- 230000003111 delayed effect Effects 0.000 description 28
- 230000001133 acceleration Effects 0.000 description 24
- 229910000831 Steel Inorganic materials 0.000 description 22
- 239000010959 steel Substances 0.000 description 22
- 230000006835 compression Effects 0.000 description 21
- 238000007906 compression Methods 0.000 description 21
- 230000000875 corresponding effect Effects 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 14
- 230000001276 controlling effect Effects 0.000 description 14
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 13
- 229940046728 tumor necrosis factor alpha inhibitor Drugs 0.000 description 13
- 239000002452 tumor necrosis factor alpha inhibitor Substances 0.000 description 13
- 101000746134 Homo sapiens DNA endonuclease RBBP8 Proteins 0.000 description 12
- 101000969031 Homo sapiens Nuclear protein 1 Proteins 0.000 description 12
- 102100021133 Nuclear protein 1 Human genes 0.000 description 12
- 230000009467 reduction Effects 0.000 description 12
- 102100040247 Tumor necrosis factor Human genes 0.000 description 11
- 229960002964 adalimumab Drugs 0.000 description 11
- 229920001971 elastomer Polymers 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 239000005060 rubber Substances 0.000 description 10
- 230000001960 triggered effect Effects 0.000 description 10
- 230000006870 function Effects 0.000 description 9
- 239000007788 liquid Substances 0.000 description 9
- 238000004873 anchoring Methods 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 238000006073 displacement reaction Methods 0.000 description 8
- 230000008713 feedback mechanism Effects 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000005284 excitation Effects 0.000 description 7
- 229960000598 infliximab Drugs 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 230000003213 activating effect Effects 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 238000003825 pressing Methods 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 5
- 230000008572 axis elongation Effects 0.000 description 5
- 230000008878 coupling Effects 0.000 description 5
- 238000010168 coupling process Methods 0.000 description 5
- 238000005859 coupling reaction Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 102000018358 immunoglobulin Human genes 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000000007 visual effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
- 230000002153 concerted effect Effects 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 229940048921 humira Drugs 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 4
- 229940071643 prefilled syringe Drugs 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000010453 quartz Substances 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960000575 trastuzumab Drugs 0.000 description 4
- 108010081589 Becaplermin Proteins 0.000 description 3
- 241000193155 Clostridium botulinum Species 0.000 description 3
- 241001492220 Echovirus E2 Species 0.000 description 3
- 241000217440 Echovirus E3 Species 0.000 description 3
- 108010029961 Filgrastim Proteins 0.000 description 3
- 102100039619 Granulocyte colony-stimulating factor Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 description 3
- 238000000540 analysis of variance Methods 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000427 antigen Substances 0.000 description 3
- 102000036639 antigens Human genes 0.000 description 3
- 108091007433 antigens Proteins 0.000 description 3
- 229960004787 becaplermin Drugs 0.000 description 3
- HYNPZTKLUNHGPM-KKERQHFVSA-N becaplermin Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]7CCCN7C(=O)[C@H](Cc8c[nH]c9c8cccc9)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N HYNPZTKLUNHGPM-KKERQHFVSA-N 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000556 factor analysis Methods 0.000 description 3
- 229960004177 filgrastim Drugs 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000012966 insertion method Methods 0.000 description 3
- 230000002045 lasting effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 238000004088 simulation Methods 0.000 description 3
- 239000002023 wood Substances 0.000 description 3
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- 108010024976 Asparaginase Proteins 0.000 description 2
- 108030001720 Bontoxilysin Proteins 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010074604 Epoetin Alfa Proteins 0.000 description 2
- 102000008070 Interferon-gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 102000051628 Interleukin-1 receptor antagonist Human genes 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 229940120638 avastin Drugs 0.000 description 2
- 229940053031 botulinum toxin Drugs 0.000 description 2
- 229940009550 c1 esterase inhibitor Drugs 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 108010067396 dornase alfa Proteins 0.000 description 2
- 229960000533 dornase alfa Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 108020001507 fusion proteins Proteins 0.000 description 2
- 102000037865 fusion proteins Human genes 0.000 description 2
- 229940044627 gamma-interferon Drugs 0.000 description 2
- 230000004886 head movement Effects 0.000 description 2
- 102000057041 human TNF Human genes 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 239000003407 interleukin 1 receptor blocking agent Substances 0.000 description 2
- 230000004807 localization Effects 0.000 description 2
- 108010092851 peginterferon alfa-2b Proteins 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 229960005267 tositumomab Drugs 0.000 description 2
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- RTQWWZBSTRGEAV-PKHIMPSTSA-N 2-[[(2s)-2-[bis(carboxymethyl)amino]-3-[4-(methylcarbamoylamino)phenyl]propyl]-[2-[bis(carboxymethyl)amino]propyl]amino]acetic acid Chemical compound CNC(=O)NC1=CC=C(C[C@@H](CN(CC(C)N(CC(O)=O)CC(O)=O)CC(O)=O)N(CC(O)=O)CC(O)=O)C=C1 RTQWWZBSTRGEAV-PKHIMPSTSA-N 0.000 description 1
- MJZJYWCQPMNPRM-UHFFFAOYSA-N 6,6-dimethyl-1-[3-(2,4,5-trichlorophenoxy)propoxy]-1,6-dihydro-1,3,5-triazine-2,4-diamine Chemical compound CC1(C)N=C(N)N=C(N)N1OCCCOC1=CC(Cl)=C(Cl)C=C1Cl MJZJYWCQPMNPRM-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 101710168454 Beta-galactosidase A Proteins 0.000 description 1
- 206010011416 Croup infectious Diseases 0.000 description 1
- 108010019673 Darbepoetin alfa Proteins 0.000 description 1
- 108010008165 Etanercept Proteins 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 101000718525 Homo sapiens Alpha-galactosidase A Proteins 0.000 description 1
- 101000959794 Homo sapiens Interferon alpha-2 Proteins 0.000 description 1
- 101001076407 Homo sapiens Interleukin-1 receptor antagonist protein Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 108010005714 Interferon beta-1b Proteins 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 229940119178 Interleukin 1 receptor antagonist Drugs 0.000 description 1
- 108700021006 Interleukin-1 receptor antagonist Proteins 0.000 description 1
- 102100030694 Interleukin-11 Human genes 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 101800004937 Protein C Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- 101800001700 Saposin-D Proteins 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 102000005262 Sulfatase Human genes 0.000 description 1
- 208000034887 Syringe issue Diseases 0.000 description 1
- 108010039185 Tenecteplase Proteins 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- XYVNHPYNSPGYLI-UUOKFMHZSA-N [(2r,3s,4r,5r)-5-(2-amino-6-oxo-3h-purin-9-yl)-4-hydroxy-2-(phosphonooxymethyl)oxolan-3-yl] dihydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H]1O XYVNHPYNSPGYLI-UUOKFMHZSA-N 0.000 description 1
- 229960000446 abciximab Drugs 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 108700025316 aldesleukin Proteins 0.000 description 1
- 229960005310 aldesleukin Drugs 0.000 description 1
- 229960000548 alemtuzumab Drugs 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229960003318 alteplase Drugs 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 229940115115 aranesp Drugs 0.000 description 1
- 229950005725 arcitumomab Drugs 0.000 description 1
- 229960003272 asparaginase Drugs 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 229960004669 basiliximab Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229940034605 capromab pendetide Drugs 0.000 description 1
- 229960003115 certolizumab pegol Drugs 0.000 description 1
- 229960005395 cetuximab Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000005253 cladding Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 201000010549 croup Diseases 0.000 description 1
- 229960002806 daclizumab Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 108010017271 denileukin diftitox Proteins 0.000 description 1
- 229960002923 denileukin diftitox Drugs 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229960001776 edrecolomab Drugs 0.000 description 1
- 229940073621 enbrel Drugs 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229960003388 epoetin alfa Drugs 0.000 description 1
- 229940089118 epogen Drugs 0.000 description 1
- 229940082789 erbitux Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 229960003297 gemtuzumab ozogamicin Drugs 0.000 description 1
- 229960001743 golimumab Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229940022353 herceptin Drugs 0.000 description 1
- 102000043404 human GLA Human genes 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 229960001001 ibritumomab tiuxetan Drugs 0.000 description 1
- 229950007354 imciromab Drugs 0.000 description 1
- 229940090438 infergen Drugs 0.000 description 1
- 230000002687 intercalation Effects 0.000 description 1
- 238000009830 intercalation Methods 0.000 description 1
- 108010010648 interferon alfacon-1 Proteins 0.000 description 1
- 229960003161 interferon beta-1b Drugs 0.000 description 1
- 229940065638 intron a Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 229920001427 mPEG Polymers 0.000 description 1
- 230000005039 memory span Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 108010046821 oprelvekin Proteins 0.000 description 1
- 229960001840 oprelvekin Drugs 0.000 description 1
- 229940035567 orencia Drugs 0.000 description 1
- 229960000402 palivizumab Drugs 0.000 description 1
- 230000006320 pegylation Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 229960000424 rasburicase Drugs 0.000 description 1
- 108010084837 rasburicase Proteins 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 108010051412 reteplase Proteins 0.000 description 1
- 229960002917 reteplase Drugs 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229960004641 rituximab Drugs 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000001338 self-assembly Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 230000003019 stabilising effect Effects 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical compound [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 1
- 108060007951 sulfatase Proteins 0.000 description 1
- 229960000216 tenecteplase Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 229960000187 tissue plasminogen activator Drugs 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 239000013638 trimer Substances 0.000 description 1
- 229960003824 ustekinumab Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M5/2033—Spring-loaded one-shot injectors with or without automatic needle insertion
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
- B23P—METAL-WORKING NOT OTHERWISE PROVIDED FOR; COMBINED OPERATIONS; UNIVERSAL MACHINE TOOLS
- B23P19/00—Machines for simply fitting together or separating metal parts or objects, or metal and non-metal parts, whether or not involving some deformation; Tools or devices therefor so far as not provided for in other classes
- B23P19/04—Machines for simply fitting together or separating metal parts or objects, or metal and non-metal parts, whether or not involving some deformation; Tools or devices therefor so far as not provided for in other classes for assembling or disassembling parts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
- A61M2005/206—With automatic needle insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2207/00—Methods of manufacture, assembly or production
- A61M2207/10—Device therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/49—Method of mechanical manufacture
- Y10T29/49764—Method of mechanical manufacture with testing or indicating
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T29/00—Metal working
- Y10T29/53—Means to assemble or disassemble
- Y10T29/53022—Means to assemble or disassemble with means to test work or product
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mechanical Engineering (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Automatic Assembly (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161454097P | 2011-03-18 | 2011-03-18 | |
| US61/454,097 | 2011-03-18 | ||
| US61/454097 | 2011-03-18 | ||
| PCT/US2012/029682 WO2012129174A1 (en) | 2011-03-18 | 2012-03-19 | Systems. devices and methods for assembling automatic injection devices and sub-asseblies thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103608053A CN103608053A (zh) | 2014-02-26 |
| CN103608053B true CN103608053B (zh) | 2016-06-22 |
Family
ID=45937593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201280023943.5A Expired - Fee Related CN103608053B (zh) | 2011-03-18 | 2012-03-19 | 用于组装自动注射装置及其子组件的系统、装置和方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20120233834A1 (enExample) |
| EP (1) | EP2686036A1 (enExample) |
| JP (1) | JP2014511711A (enExample) |
| CN (1) | CN103608053B (enExample) |
| AU (1) | AU2012231178B2 (enExample) |
| BR (1) | BR112013023967A2 (enExample) |
| CA (1) | CA2829773A1 (enExample) |
| MX (1) | MX2013010699A (enExample) |
| WO (1) | WO2012129174A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0414054D0 (en) | 2004-06-23 | 2004-07-28 | Owen Mumford Ltd | Improvements relating to automatic injection devices |
| CN101087625B (zh) | 2004-11-22 | 2012-02-22 | 因特利杰克特有限公司 | 用于药物供给的装置和系统 |
| US7648483B2 (en) | 2004-11-22 | 2010-01-19 | Intelliject, Inc. | Devices, systems and methods for medicament delivery |
| NZ560516A (en) | 2005-02-01 | 2010-12-24 | Intelliject Inc | A delivery system where a medicant is automatically delivered on activation as well as a recorded instruction |
| US8361026B2 (en) | 2005-02-01 | 2013-01-29 | Intelliject, Inc. | Apparatus and methods for self-administration of vaccines and other medicaments |
| US9022980B2 (en) | 2005-02-01 | 2015-05-05 | Kaleo, Inc. | Medical injector simulation device |
| US8231573B2 (en) | 2005-02-01 | 2012-07-31 | Intelliject, Inc. | Medicament delivery device having an electronic circuit system |
| US8206360B2 (en) | 2005-02-01 | 2012-06-26 | Intelliject, Inc. | Devices, systems and methods for medicament delivery |
| KR101440795B1 (ko) | 2006-06-30 | 2014-09-22 | 애브비 바이오테크놀로지 리미티드 | 자동 주사 장치 |
| US8021344B2 (en) | 2008-07-28 | 2011-09-20 | Intelliject, Inc. | Medicament delivery device configured to produce an audible output |
| USD994111S1 (en) | 2008-05-12 | 2023-08-01 | Kaleo, Inc. | Medicament delivery device cover |
| US8636704B2 (en) | 2009-04-29 | 2014-01-28 | Abbvie Biotechnology Ltd | Automatic injection device |
| KR101780210B1 (ko) | 2009-12-15 | 2017-09-21 | 애브비 바이오테크놀로지 리미티드 | 자동 주사 디바이스용 개선된 발사 버튼 |
| CN104906656B (zh) | 2010-04-21 | 2020-01-10 | 艾伯维生物技术有限公司 | 用于治疗药剂的受控输送的可佩戴自动注射装置 |
| MX336571B (es) | 2011-01-24 | 2016-01-25 | Elcam Medical Agricultural Cooperative Ass Ltd | Inyector. |
| MY166835A (en) | 2011-01-24 | 2018-07-23 | Abbvie Biotechnology Ltd | Automatic injection devices having overmolded gripping surfaces |
| CN105709312B (zh) | 2011-01-24 | 2019-11-05 | 艾伯维生物技术有限公司 | 从注射器拆卸针罩和自动注射装置 |
| US8627816B2 (en) | 2011-02-28 | 2014-01-14 | Intelliject, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| US9173999B2 (en) | 2011-01-26 | 2015-11-03 | Kaleo, Inc. | Devices and methods for delivering medicaments from a multi-chamber container |
| US8939943B2 (en) | 2011-01-26 | 2015-01-27 | Kaleo, Inc. | Medicament delivery device for administration of opioid antagonists including formulations for naloxone |
| ES2659491T3 (es) * | 2012-09-05 | 2018-03-15 | E3D Agricultural Cooperative Association Ltd. | Dispositivo de autoinyección electrónico |
| US20150290396A1 (en) * | 2012-10-23 | 2015-10-15 | Insuline Medical Ltd. | Drug dispensing-tracking device, system and method |
| US9381647B2 (en) * | 2013-02-19 | 2016-07-05 | Seiko Epson Corporation | Force detection device, robot, and moving object |
| US20140260694A1 (en) * | 2013-03-15 | 2014-09-18 | Chevron U.S.A. Inc. | Automated Tracer Sampling and Measurement System |
| WO2015024960A1 (en) * | 2013-08-22 | 2015-02-26 | Sanofi-Aventis Deutschland Gmbh | Control unit for a drug delivery device |
| FR3014969B1 (fr) * | 2013-12-16 | 2016-01-29 | Lisi Aerospace | Fixation temporaire |
| US10625026B2 (en) | 2014-01-21 | 2020-04-21 | Parenteral Technologies, Llc | Force actuated injection device |
| US20150202373A1 (en) * | 2014-01-21 | 2015-07-23 | Parenteral Technologies, Llc | Force actuated injection device |
| US9517307B2 (en) | 2014-07-18 | 2016-12-13 | Kaleo, Inc. | Devices and methods for delivering opioid antagonists including formulations for naloxone |
| JP6859253B2 (ja) * | 2014-08-08 | 2021-04-14 | サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | デバイス内部に配置されたカートリッジの機械的完全性を試験するための方法、構成、および薬物送達デバイス |
| CA3009221A1 (en) | 2014-12-23 | 2016-06-30 | Automed Pty Ltd | Delivery apparatus, system and associated methods |
| CN107530502B (zh) | 2015-02-20 | 2021-01-15 | 里珍纳龙药品有限公司 | 注射器系统、活塞密封系统、塞子系统 |
| WO2017004345A1 (en) | 2015-06-30 | 2017-01-05 | Kaleo, Inc. | Auto-injectors for administration of a medicament within a prefilled syringe |
| WO2017033193A2 (en) * | 2015-08-27 | 2017-03-02 | E3D Agricultural Cooperative Association Ltd | Reusable automatic injection device |
| WO2017087888A1 (en) | 2015-11-18 | 2017-05-26 | President And Fellows Of Harvard College | Systems and methods for monitoring, managing, and treating asthma and anaphylaxis |
| CN106236319B (zh) * | 2016-09-29 | 2017-12-29 | 深圳市智屏微科技有限公司 | 一种注射器的注射端结构以及注射器 |
| AU2017379094B2 (en) | 2016-12-23 | 2023-08-24 | Kaleo, Inc. | Medicament delivery device and methods for delivering drugs to infants and children |
| WO2019012475A2 (en) | 2017-07-12 | 2019-01-17 | Insuline Medical Ltd. | DRUG MONITORING DEVICE |
| GB201718315D0 (en) * | 2017-11-06 | 2017-12-20 | Owen Mumford Ltd | Auto-injector |
| US12171990B2 (en) | 2017-12-28 | 2024-12-24 | Sanofi | Sensor device for attachment to an injection device |
| CA3099359A1 (en) | 2018-05-24 | 2019-11-28 | Novartis Ag | Automatic drug delivery device |
| WO2020140040A1 (en) | 2018-12-29 | 2020-07-02 | Kaleo, Inc. | Devices and methods for delivery of substances within a prefilled syringe |
| IL290026B1 (en) | 2019-08-09 | 2025-10-01 | Kaleo Inc | Devices and methods for transferring materials into a prefilled syringe |
| US11829795B2 (en) * | 2019-12-30 | 2023-11-28 | UiPath, Inc. | Trigger service management for robotic process automation (RPA) |
| CN115515665A (zh) * | 2020-04-06 | 2022-12-23 | 辉美医疗器械有限公司 | 用于组装用在自动注射装置中的一盒子的方法 |
| US11957542B2 (en) | 2020-04-30 | 2024-04-16 | Automed Patent Holdco, Llc | Sensing complete injection for animal injection device |
| WO2022010726A1 (en) | 2020-07-09 | 2022-01-13 | Eli Lilly And Company | Automatic injection device with reusable portion |
| US12268847B1 (en) | 2021-02-10 | 2025-04-08 | Kaleo, Inc. | Devices and methods for delivery of substances within a medicament container |
| CN118785935A (zh) * | 2022-03-11 | 2024-10-15 | 赛诺菲 | 用于注射装置的工件载体 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3541663A (en) * | 1968-08-21 | 1970-11-24 | Roman Szpur | Syringe needle attachment device |
| US6692469B1 (en) * | 1997-07-31 | 2004-02-17 | Ares-Trading S.A. | Injection devices |
| CN101484199A (zh) * | 2006-06-30 | 2009-07-15 | 艾博特生物技术有限公司 | 自动注射装置 |
| CN101522240A (zh) * | 2006-09-28 | 2009-09-02 | 罗伯特·博世有限公司 | 用于将针保护件安装到注射器体上的装置和方法 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910260A (en) | 1972-03-01 | 1975-10-07 | Survival Technology | Method and apparatus of treating heart attack patients prior to the establishment of qualified direct contact personal care |
| US4004577A (en) | 1972-12-04 | 1977-01-25 | Survival Technology, Inc. | Method of treating heart attack patients prior to the establishment of qualified direct contact personal care |
| US3941130A (en) | 1975-03-18 | 1976-03-02 | Tibbs Robert C | Sequential trigger release for injection device |
| US4261358A (en) | 1979-10-01 | 1981-04-14 | Walter Vargas | Automatic syringe plunger |
| US4795433A (en) | 1985-05-20 | 1989-01-03 | Survival Technology, Inc. | Automatic injector for emergency treatment |
| US4689042A (en) | 1985-05-20 | 1987-08-25 | Survival Technology, Inc. | Automatic medicament ingredient mixing and injecting apparatus |
| US4855923A (en) * | 1988-01-06 | 1989-08-08 | Xerox Corporation | Parts assembly using signature analysis |
| US5142769A (en) * | 1988-07-14 | 1992-09-01 | Coors Brewing Company | Monitor and control assembly for use with a can end press |
| US5085642A (en) | 1989-07-17 | 1992-02-04 | Survival Technology, Inc. | Conveniently carried frequent use autoinjector |
| US5102393A (en) | 1989-07-17 | 1992-04-07 | Survival Technology, Inc. | Autoinjector converted from intramuscular to subcutaneous mode of injection |
| US6448380B2 (en) | 1989-08-07 | 2002-09-10 | Peptech Limited | Tumor necrosis factor antibodies |
| US5959087A (en) | 1989-08-07 | 1999-09-28 | Peptide Technology, Ltd. | Tumour necrosis factor binding ligands |
| AU630497B2 (en) | 1989-09-05 | 1992-10-29 | Immunex Corporation | Tumor necrosis factor-alpha and -beta receptors |
| US5092843A (en) | 1990-04-12 | 1992-03-03 | Survival Technology, Inc. | Dispersion multichamber auto-injector |
| IT1246154B (it) * | 1990-07-13 | 1994-11-15 | Italtractor | Metodo per accoppiare gli elementi di una articolazione con gioco di funzionamento prestabilito mediante l'esecuzione di collegamenti forzati |
| US5656272A (en) | 1991-03-18 | 1997-08-12 | New York University Medical Center | Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies |
| US5267963A (en) | 1992-08-21 | 1993-12-07 | Nicholas Bachynsky | Medication injection device |
| JPH07504203A (ja) | 1992-09-15 | 1995-05-11 | イミュネックス・コーポレーション | 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法 |
| US6090382A (en) | 1996-02-09 | 2000-07-18 | Basf Aktiengesellschaft | Human antibodies that bind human TNFα |
| DE69721548T2 (de) | 1996-02-09 | 2004-04-01 | Abbott Laboratories(Bermuda)Ltd. | HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN |
| DE19705462C2 (de) * | 1997-02-13 | 2002-01-10 | Schmidt Feinmech | Verfahren zum Betreiben einer Elektropresse |
| US6149626A (en) | 1997-10-03 | 2000-11-21 | Bachynsky; Nicholas | Automatic injecting syringe apparatus |
| SE9803662D0 (sv) | 1998-10-26 | 1998-10-26 | Pharmacia & Upjohn Ab | Autoinjector |
| UA81743C2 (uk) | 2000-08-07 | 2008-02-11 | Центокор, Инк. | МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ |
| JP3978785B2 (ja) * | 2003-09-10 | 2007-09-19 | ニプロ株式会社 | 外れ防止機構を備えたプランジャー |
| WO2005115514A1 (en) * | 2004-05-28 | 2005-12-08 | Cilag Gmbh International | Injection device |
| PL2099584T3 (pl) * | 2006-07-18 | 2018-01-31 | Kistler Holding Ag | Łączący zespół |
| IL177036A (en) * | 2006-07-23 | 2011-05-31 | Sagiv Agudah Shitufit Chaklait Be Am | Device and method for connecting a pipe fitting to a pipe |
| JP2010279692A (ja) * | 2009-05-26 | 2010-12-16 | Mg2 Srl | 注射器のピストンを捩じ込むための方法及び装置 |
-
2012
- 2012-03-19 JP JP2013558239A patent/JP2014511711A/ja not_active Ceased
- 2012-03-19 MX MX2013010699A patent/MX2013010699A/es unknown
- 2012-03-19 CA CA2829773A patent/CA2829773A1/en not_active Abandoned
- 2012-03-19 AU AU2012231178A patent/AU2012231178B2/en not_active Ceased
- 2012-03-19 US US13/424,194 patent/US20120233834A1/en not_active Abandoned
- 2012-03-19 EP EP12713470.8A patent/EP2686036A1/en not_active Withdrawn
- 2012-03-19 BR BR112013023967A patent/BR112013023967A2/pt not_active Application Discontinuation
- 2012-03-19 CN CN201280023943.5A patent/CN103608053B/zh not_active Expired - Fee Related
- 2012-03-19 WO PCT/US2012/029682 patent/WO2012129174A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3541663A (en) * | 1968-08-21 | 1970-11-24 | Roman Szpur | Syringe needle attachment device |
| US6692469B1 (en) * | 1997-07-31 | 2004-02-17 | Ares-Trading S.A. | Injection devices |
| CN101484199A (zh) * | 2006-06-30 | 2009-07-15 | 艾博特生物技术有限公司 | 自动注射装置 |
| CN101522240A (zh) * | 2006-09-28 | 2009-09-02 | 罗伯特·博世有限公司 | 用于将针保护件安装到注射器体上的装置和方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2012231178A1 (en) | 2013-05-02 |
| WO2012129174A1 (en) | 2012-09-27 |
| EP2686036A1 (en) | 2014-01-22 |
| MX2013010699A (es) | 2014-03-27 |
| JP2014511711A (ja) | 2014-05-19 |
| CA2829773A1 (en) | 2012-09-27 |
| CN103608053A (zh) | 2014-02-26 |
| AU2012231178B2 (en) | 2015-11-05 |
| US20120233834A1 (en) | 2012-09-20 |
| BR112013023967A2 (pt) | 2016-01-19 |
| WO2012129174A8 (en) | 2013-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103608053B (zh) | 用于组装自动注射装置及其子组件的系统、装置和方法 | |
| CN103702702B (zh) | 自动注射装置中的改进的护罩展开 | |
| US20250018121A1 (en) | Wearable automatic injection device for controlled administration of therapeutic agents | |
| KR102202772B1 (ko) | 오버몰딩된 파지면을 갖는 자동 주사 장치 | |
| CN102458517B (zh) | 自动注射装置 | |
| JP2025517122A (ja) | 注入デバイスの動作を検出又は認識するためのセンサアセンブリ | |
| HK1195020B (en) | Wearable automatic injection device |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160622 Termination date: 20180319 |